Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

'Lab on a Chip' Might Speed Breast Cancer Monitoring

Device makes measuring estrogen faster and simpler, researchers say

By Kathleen Doheny
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
AIDS and HIV Infection
Amenorrhea
Amniocentesis
More...

Related Healthscout Videos
 border=
Optimistic Healing
Early Babies: How Soon is Too Soon?
Aqua Lipo
Cancer Treatment for Any Size
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Colon Cancer
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Cialis
Detrol LA
Diflucan
More...

Related News Articles
 border=
Health Tip: Opt for Weight-Bearing Exercises
Med Students Often Fail to Report Needlestick Injuries
Taxol Boosts Odds of Chronic Pain
U.S. Records Increase in Kids With Down Syndrome
More...

WEDNESDAY, Oct. 7 (HealthDay News) -- A pocket-size device under development could soon help monitor how well breast cancer treatments are working and help assess breast cancer risk by measuring levels of the hormone estrogen.

''We've developed a 'lab on a chip,' which is useful for making quantitative measurements of estrogen in samples of blood or tissue," said Aaron Wheeler, the Canada research chair of bioanalytical chemistry at the University of Toronto and a co-author of a report on the device in the Oct. 7 issue of Science Translational Medicine.

Text Continues Below



The new device relies on a method called digital microfluidics. The technique is being used to analyze hormones found in tiny samples of blood, serum and breast cancer tissue.

Instead of moving electrons across tiny wires, it electronically manipulates minute droplets of fluid on the surface of a microchip, integrating many different lab functions so fewer are needed, Wheeler explained during a teleconference briefing Oct. 6. Hormones are extracted, purified and analyzed. And it's all done on a device that can fit on the palm of the hand, he said.

The "lab on a chip" technique, already under study in other areas, takes raw, unprocessed tissue and delivers results rapidly, Wheeler said. Estrogen can be measured in minutes.

It also requires much tinier samples than those needed by conventional methods, said Dr. Noha Mousa, also a co-author of the report, who is working on her Ph.D. in medicine at the University of Toronto. "This is 1,000 times smaller than the tissue samples required" by other methods, she said.

For their report, the technique was tested on breast tissue from two postmenopausal breast cancer patients.

Estrogen concentrations are not routinely measured because doing so with conventional methods requires large samples, the researchers noted in their report. But they said that a simpler measuring technique would, for instance, allow doctors to monitor treatment with aromatase inhibitors routinely given to breast cancer patients to block estrogen.

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 10/7/2009

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Aaron Wheeler, Ph.D., Canada research chairman, bioanalytical chemistry, University of Toronto; Noha Mousa, M.D., Institute of Medicine, University of Toronto; Susan M. Gapstur, Ph.D., M.P.H., vice president, epidemiology, American Cancer Society, Atlanta; Oct. 7, 2009, Science Translational Medicine


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy